We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Combined Biosensor Strategy Detects Infectious Pathogens

By LabMedica International staff writers
Posted on 14 Jun 2013
A method has been developed that combines deoxyribozyme technology with gold nanoparticles to give a simple point-of-care (POC) diagnostic technique that can be used in remote settings.

The technique merges the colorimetric coupling of surface plasmons of gold nanoparticles (GNPs) with deoxyribozyme (DNAzyme) signal amplification technology to create a fast and simple detection method for genetic targets with a simple colorimetric readout.

Chemical engineers at the University of Toronto (ON, Canada) implemented a genetic sensing assay in a simple two-step system. More...
In the amplification step, a buffered mix of multicomponent nucleic acid enzymes (MNAzymes) and linkers is added to the sample solution and incubated at 50 °C for one hour. If target sequences are present, they bind and activate the MNAzymes. Each active MNAzyme in turn catalyzes cleavage of multiple linkers, which effectively translates into signal amplification.

Any linkers that remained uncleaved caused aggregation of the corresponding GNP pairs, turning the solution purple. In contrast, linkers cleaved by target-activated MNAzymes were not able to cross-link the associated GNP pairs, and solution remained red. In one test for the pathogen Neisseria gonorrhoeae, the mixtures in the specific detection tubes remained red. Following this method, the scientist successfully detected five targets simultaneously. In addition, the assay with lyophilized components was used to correctly identify gonorrhea, malaria, and hepatitis B virus sequences in a sample mixture that contained three out of the five targets. All RNA-containing Linker DNA strands were obtained from Integrated DNA Technologies (Coralville, IA, USA) in purified lyophilized form and all other DNA sequences were from BioBasic (Markham, ON, Canada).

The authors concluded that the assay can detect multiple genetic sequences in parallel and that it could be easily applied to other nucleic acid targets. The color-based readout does not require any complex equipment and uses stable and cost-effective reagents, making this approach particularly suitable for POC testing. Warren C. W. Chan, PhD, a professor in nanobiotechnology and the senior author, said, “There's been a lot of emphasis in developing simple diagnostics. The question is how do you make it simple enough, portable enough? Gold is the best medium, because it's easy to see. It emits a very intense color." The article was published on March 11, 2013, in the journal Angewandte Chemie.

Related Links:

University of Toronto

Integrated DNA Technologies

BioBasic





New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.